Best practices kept coronavirus cases at zero among hospital employees, study finds
By
Alicia Lasek
Mar 05, 2020
The hospital’s strategy was to step up screening and quarantine, along with infection control measures during the early weeks of the outbreak.
Coordinate locally to lower COVID-19 burden, facility study suggests
By
Alicia Lasek
Oct 13, 2020
Three Michigan nursing homes worked hand-in-hand with local referral hospitals and labs to successfully contain facility COVID-19 outbreaks.
Calculator predicts elders’ need for palliative care
By
Alicia Lasek
Jul 07, 2021
A new online tool can help frail older adults and their clinicians estimate six-month life expectancy and better plan for end-of-life care, according to real-world studies from Canada.
Tests conducted in a Chicago skilled nursing facility found that patients who harbor the candida auris fungus shed it, likely contaminating their surroundings.
New CMS guidance nudges nursing homes to offer COVID shots, timely treatments
By
Alicia Lasek
Nov 23, 2022
The agency reminds nursing facilities of the requirement to actively offer updated COVID vaccines and urges them to provide approved treatments early to keep mild symptoms from escalating.
Skilled nursing facility guidance part of Arizona’s revised crisis care plan
By
Alicia Lasek
May 27, 2021
The revisions include guidance on honoring care and treatment preferences in federal skilled nursing facilities. The changes follow a complaint against the state brought by national and local disability...
Use of common sleep meds nosedives, with 86 percent drop in oldest adults
By
Alicia Lasek
Aug 17, 2022
The use of sleep medications among Americans dropped by 31% just prior to the pandemic, with the steepest decline among adults aged 80 and older, investigators report.
FDA advisers to vote on first drug to treat Alzheimer’s
By
Alicia Lasek
Oct 28, 2020
Advisers will consider whether to recommend that the amyloid beta-removing drug aducanumab be approved. The FDA has not reviewed an application for a new Alzheimer’s treatment for at least 15 years.
U.S. vaccine acceptance grows by 20 percent from 2021 to 2022: survey
By
Alicia Lasek
Jan 12, 2023
“Vaccination remains a cornerstone of the COVID-19 pandemic response, but broad public support remains elusive,” the researchers said.
J&J delaying vaccine trials due to ‘unexplained illness’
By
Alicia Lasek
Oct 14, 2020
Late-stage COVID-19 vaccine trials by Johnson & Johnson have been temporarily halted due to an “unexplained illness in a study participant,” the company reported Monday.